Name Ihor Lemischka | ||
Education Johns Hopkins University, Massachusetts Institute of Technology |
Ihor R. Lemischka, Ph.D. is an internationally recognized stem cell biologist and stem cell research advocate and currently both the Lillian and Henry M. Stratton Professor of Gene and Cell Medicine and Director of the Black Family Stem Cell Institute at Mount Sinai Medical Center in New York City.
Contents
- Education and post doctoral training
- Academic appointments
- Affiliations and awards
- Patents
- Areas of concentration
- Publications
- References
His work with hematopoietic stem cells (HSC) was the first to identify their novel receptor tyrosine kinases and showed that HSC can rebuild all blood cell types in a mouse whose blood cells had been destroyed.
He has authored over 70 book chapters and publications in peer-reviewed journals.
Education and post-doctoral training
Lemischka graduated from Johns Hopkins University in 1976 and earned his Ph.D in biology from MIT in 1983. He did his post-doctoral training at MIT's Whitehead Institute.
Academic appointments
Lemischka joined Princeton University in 1986 as Assistant Professor of Molecular Biology; he became Professor in 2002. In 2007, he joined the staff at Mount Sinai Medical Center, where he is currently Professor of Gene and Cell Medicine and Director of the Black Family Stem Cell Institute.
Affiliations and awards
Lemischka is a board member of the International Society for Stem Cell Research, the Journal of Visualized Experiments (JoVE) and the New York Stem Cell Foundation. His awards include a Damon Runyon-Walter Winchell Postdoctoral, a Leukemia Social Special Fellowship, an American Cyanamid Preceptorship Award and the DuPont Young Faculty Grant. He is a journal reviewer for Cell, Science, Nature, Nature Genetics, Nature Immunology, Nature Biotechnology, Proceedings of the National Academy of Sciences, Public Library of Science, Development, Genes & Development, Journal of Clinical Investigation and Blood.
Patents
Lemischka holds or has patents pending for the following:
Areas of concentration
Lemischka's interests include defining the cellular and molecular mechanisms that control cell fate decisions in embryonic stem cells. Research into mouse embryonic stem cells is currently being aggressively studied in the embryonic stem cells of humans.
Publications
Partial List: